FDA lifts partial clinical hold on Rezolute hypoglycemia treatment
Resolute said the U.S. Food and Drug Administration has lifted the partial clinical hold on its late-stage study testing its treatment for low blood sugar, sending its shares up 11% to $4.83.
ПОПУЛЯРНЫЕ ПОСТЫ
Bluetongue outbreak in a Portuguese sheep farm has broken out
Сентябрь 19, 2024
Austria says disaster fund to rise to 1 billion euros
Сентябрь 19, 2024
Portugal gets help from Spain and Morocco in response to fires
Сентябрь 19, 2024
Drought reduces Amazon rivers to historic lows
Сентябрь 19, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ